DCM
MDCO

Decatur Capital Management’s Medicines Co MDCO Stock Holding History

Decatur Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-95,225
Closed -$2.71M – 103
2014
Q1 		$2.71M Hold
95,225
– – 0.52% 74
2013
Q4 		$3.68M Buy
95,225
+4,300
+5% +$154K 0.71% 59
2013
Q3 		$3.05M Buy
90,925
+68,150
+299% +$2.17M 0.64% 66
2013
Q2 		$701K Buy
+22,775
New +$762K 0.24% 80

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Decatur Capital Management's MDCO Position: Q2 2014 in Review

Decatur Capital Management sold out of Medicines Co (MDCO) in Q2 2014, closing a stake of 95,225 shares — an estimated $2.71M sold.

Decatur Capital Management first reported a position in MDCO in Q2 2013 and held it in 4 quarters. The position peaked at $3.68M in Q4 2013. 152 funds tracked by Wall St. Rank hold MDCO as of Q2 2014.

  • Decatur Capital Management reported no remaining Medicines Co position as of Q2 2014 after selling out during the quarter.
  • Decatur Capital Management sold 95,225 Medicines Co shares in Q2 2014, an estimated $2.71M.
  • Decatur Capital Management first reported a position in Medicines Co in Q2 2013 and held it in 4 quarters.
  • Decatur Capital Management's Medicines Co position peaked at $3.68M in Q4 2013.
  • 152 funds tracked by Wall St. Rank held Medicines Co as of Q2 2014.

Based on Decatur Capital Management's 13F filing for Q2 2014, filed 15 Jul 2014.